Overactive bladder comprises a spectrum of conditions ranging from urgency-frequency syndrome to urge incontinence. The incidence of overactive bladder increases with age, with a prevalence exceeding 4% to 5.5% of the population. Its etiology is not clearly understood, and the treatment options often have poor efficacy and significant side effects.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.
Personalized therapeutic approaches in ccRCC remain challenging
April 15th 2024"As a kidney cancer community, we need to investigate these molecular subtypes prospectively in clinical trials to determine whether specific subtypes benefit from certain therapies or not," says David A. Braun, MD, PhD.